Microbot Medical Inc.MBOTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-6.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-49.26%
Q2 202510.56%
Q1 2025-70.02%
Q4 202438.46%
Q3 2024-40.69%
Q2 202419.43%
Q1 2024-34.03%
Q4 2023-7.90%
Q3 20239.71%
Q2 202341.80%
Q1 2023-29.99%
Q4 202216.76%
Q3 20227.09%
Q2 2022-5.39%
Q1 2022-3.14%
Q4 2021-33.84%
Q3 20214.91%
Q2 2021-15.21%
Q1 2021-19.13%
Q4 20201.35%
Q3 2020-184.00%
Q2 2020183.89%
Q1 2020-13.01%
Q4 2019-60.48%
Q3 2019-179.04%
Q2 201982.48%
Q1 2019-91.90%
Q4 2018-5.35%
Q3 20186.46%
Q2 2018-8.52%
Q1 20180.90%
Q4 20170.74%
Q3 20176.12%
Q2 2017-82.13%
Q1 2017-103.33%
Q4 20165727.58%
Q3 2016-573.60%
Q2 201699.32%
Q1 2016-32.45%
Q4 20159.55%